View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Enfortumab Vedotin 1.25 / Pembrolizumab 200 - Pembrolizumab 200, Bladder Cancer, perioperative, cycles 10–17
Protocol-ID: 3148 V1.1 (Mini), ENFVED1.25/PEMB200 - PEMB200, Bladder Cancer, perioperative, C10-17Indication(s)
- Bladder Cancer; ICD-10 C67.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 13.07.2026